Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 1-3”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03445650
What this trial is testing

RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS)

Who this might be right for
Sjogren-Larsson Syndrome
Aldeyra Therapeutics, Inc. 11
Large-scale testing (Phase 3)WithdrawnNCT01590225
What this trial is testing

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Early research (Phase 1)Study completedNCT04645940
What this trial is testing

Fruquintinib Food Effect and Proton Pump Inhibitor Study

Who this might be right for
Drug InteractionFood-drug Interaction
Hutchison Medipharma Limited 14
Testing effectiveness (Phase 2)Study completedNCT00005985
What this trial is testing

Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Masonic Cancer Center, University of Minnesota 213
Testing effectiveness (Phase 2)Study completedNCT02895750
What this trial is testing

Efficacity and Safety of Metformin XR in CKD Stage 1 to 3

Who this might be right for
Renal Insufficiency, Chronic
Centre Hospitalier Universitaire, Amiens 12
Testing effectiveness (Phase 2)Ended earlyNCT01164150
What this trial is testing

Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06

Who this might be right for
Endometrial CancerGastrointestinal ComplicationsRadiation Toxicity+1 more
Cancer Trials Ireland 92
Not applicableLooking for participantsNCT07469267
What this trial is testing

Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases

Who this might be right for
Breast CancerRadiotherapy
Fudan University 1,608
Large-scale testing (Phase 3)Not Yet RecruitingNCT07785687
What this trial is testing

Comparing Radiation After Surgery to Observation After Surgery in Patients With Clinical Low-Risk, Molecular High-Risk Meningioma, and Evaluating Observation After Surgery in Patients With Clinical and Molecular Low-Risk Meningioma

Who this might be right for
Grade 1 MeningiomaGrade 2 MeningiomaRecurrent Grade 1 Meningioma
NRG Oncology 464
Large-scale testing (Phase 3)Not Yet RecruitingNCT07526792
What this trial is testing

SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 406
Large-scale testing (Phase 3)Study completedNCT01074944
What this trial is testing

Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 170
Not applicableStudy completedNCT00829101
What this trial is testing

Articulation and Phonology in Children With Unilateral Cleft Lip and Palate

Who this might be right for
Cleft PalateCleft Lip
Region Skane 30
Large-scale testing (Phase 3)Looking for participantsNCT07486934
What this trial is testing

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy Type 1 (DM1)DM1Myotonic Dystrophy+2 more
Dyne Therapeutics 150
Testing effectiveness (Phase 2)Ended earlyNCT01701063
What this trial is testing

An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 42
Large-scale testing (Phase 3)Looking for participantsNCT07071623
What this trial is testing

MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC 4,580
Large-scale testing (Phase 3)Active Not RecruitingNCT04562389
What this trial is testing

Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis

Who this might be right for
Myelofibrosis
Karyopharm Therapeutics Inc 353
Early research (Phase 1)Study completedNCT02266940
What this trial is testing

Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets

Who this might be right for
Healthy
Daiichi Sankyo 18
Early research (Phase 1)Study completedNCT00004189
What this trial is testing

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT03014297
What this trial is testing

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

Who this might be right for
Neuroendocrine TumorsEverolimus
Lowell Anthony, MD 17
Large-scale testing (Phase 3)Looking for participantsNCT07081997
What this trial is testing

Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism

Who this might be right for
HypoparathyroidismEndocrine System DiseasesParathyroid Diseases
Ascendis Pharma Bone Diseases A/S 36
Early research (Phase 1)Looking for participantsNCT05473910
What this trial is testing

T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
AMLMDS
TScan Therapeutics, Inc. 310
Next Page